Loading organizations...
Jaquet Partners operates as an investment firm and family office, strategically managing a diverse portfolio with an emphasis on sustainable, long-term value preservation. The firm's approach encompasses direct real estate planning and development, alongside private equity investments in Swiss small and mid-cap companies across industrial, technology, medical, and biotech sectors. They also deploy venture capital into promising early-stage Swiss start-ups, complementing these with investments in listed companies and carefully selected funds.
The firm was founded by brothers Marc Jaquet and Olivier Jaquet, leveraging their combined entrepreneurial and financial expertise accumulated over several decades. Marc, having previously expanded and sold the family business Jaquet Technology Group, brings significant operational leadership, while Olivier, a Dr. iur., boasts over two decades in the finance industry, including CEO roles at various financial institutions. Their insight stemmed from a shared conviction to apply a hands-on, responsible approach to capital management and strategic investment.
Jaquet Partners primarily deploys capital into companies and real assets that align with their ethos of long-term value. The firm’s vision centers on the meticulous preservation and growth of assets through active, committed management and a strong belief in the foundational businesses they support. They remain dedicated to identifying first-class opportunities with sustainable business models, ensuring prudent oversight for future generations.
Jaquet Partners has 1 tracked investment across 1 company. The latest tracked deal is $15.5M Series B in Memo Therapeutics in November 2020.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 6, 2020 | Memo Therapeutics | $15.5M Series B | Robert Schier | Bettina Ernst, Redalpine, Schroder Adveq, Verve Ventures |